| P50 | author | Koen Pouwels | Q42880588 |
| P2093 | author name string | E Hak | |
| | M J Postma | |
| | W Luytjes | |
| | M J Meijboom | |
| P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| | Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics | Q23915053 |
| | Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 |
| | Strategy for distribution of influenza vaccine to high-risk groups and children. | Q30350117 |
| | The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study | Q30400700 |
| | Prevalence estimates of multimorbidity: a comparative study of two sources | Q33575010 |
| | Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 |
| | Respiratory syncytial virus infection in elderly and high-risk adults | Q34414401 |
| | Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. | Q34471065 |
| | Antibody response to influenza vaccination in the elderly: a quantitative review | Q36280602 |
| | Preference-Based EQ-5D index scores for chronic conditions in the United States | Q36541277 |
| | Biology of immune responses to vaccines in elderly persons | Q37150299 |
| | Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial | Q37180854 |
| | The timing of influenza vaccination for older adults (65 years and older). | Q37437954 |
| | Acute respiratory tract infection in daycare centers for older persons | Q37887708 |
| | Intensive surveillance for infections in a three-year study of nursing home patients | Q38470969 |
| | Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race | Q40580983 |
| | An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine | Q40940832 |
| | Rate-difference method proved satisfactory in estimating the influenza burden in primary care visits | Q44456122 |
| | Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands | Q45357826 |
| | Influenza- and respiratory syncytial virus-associated mortality and hospitalisations | Q45400993 |
| | Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods | Q45407392 |
| | The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly | Q45745318 |
| | Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults | Q45768811 |
| | Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population | Q45823296 |
| | Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine | Q45823297 |
| | Immunity to and frequency of reinfection with respiratory syncytial virus | Q45853042 |
| | Humoral immunity to respiratory syncytial virus infection in the elderly | Q45866710 |
| | Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children | Q45888997 |
| | Multimorbidity in primary care: prevalence and trend over the last 20 years. | Q51676563 |
| | Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. | Q51914599 |
| | A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. | Q53069448 |
| | Viral Respiratory Infections in the Institutionalized Elderly: Clinical and Epidemiologic Findings | Q67755051 |
| | No immunity for the elderly | Q77078185 |
| | Vaccine development strategies for improving immunization: the role of modern immunology | Q80020558 |
| | Respiratory syncytial virus infection in adults | Q80216008 |
| | Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement rates | Q81422906 |
| | Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination | Q82910140 |
| P433 | issue | 52 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 6254-6260 | |
| P577 | publication date | 2013-10-19 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly population | |
| P478 | volume | 31 | |